Dr Reddys may begin Sputnik-V trials in next few weeks: Executive Ruchika Sharma23 Sept 2020 9:15 AMBengaluru: Dr Reddy's Laboratories Ltd could begin late-stage Indian clinical trials of Russia's potential coronavirus vaccine in the next few weeks,...
Dr Reddys may begin Sputnik-V trials in next few weeks: Executive Ruchika Sharma23 Sept 2020 9:15 AMBengaluru: Dr Reddy's Laboratories Ltd could begin late-stage Indian clinical trials of Russia's potential coronavirus vaccine in the next few weeks,...
Dr Reddys settles patent litigation over cancer drug Revlimid with Celgene in US Ruchika Sharma19 Sept 2020 4:15 AMRevlimid is used to treat multiple myeloma and myelodysplastic syndromes.
RDIF collaborates with Dr Reddys for supply of 100 million doses of Sputnik V in India Ruchika Sharma17 Sept 2020 7:04 AMDeliveries could potentially begin in late 2020, subject to completion of successful trials and registration of the vaccine by regulatory authorities...
Dr Reddys unveils COVID-19 drug Remdesivir under brand name Redyx in India Medical Dialogues Bureau10 Sept 2020 8:46 AM"Dr Reddy's Redyx is available in the strength of 100 mg vial," dr Reddy's said.
Dr Reddys unveils generic Fulvestrant injection for breast cancer in US Ruchika Sharma8 Sept 2020 6:10 AMFaslodex is a prescription medicine used to treat advanced breast cancer or breast cancer that has spread to other parts of the body.
Dr Reddys unveils Methylphenidate Hydrochloride ER Tablets in US Ruchika Sharma4 Sept 2020 6:09 AMConcerta is indicated to treat attention deficit hyperactivity disorder(ADHD).
Wockhardt Pharma reports net profit at Rs 760 crore in Q1 Farhat Nasim31 Aug 2020 7:29 AMNew Delhi: Drug firm Wockhardt NSE -4.42 % on Saturday reported a consolidated net profit of Rs 759.75 crore for June quarter mainly on account of...
Dr Reddys Labs: USFDA closes warning letter for three sites Ruchika Sharma30 Aug 2020 4:45 AMIn November 2015, Dr Reddy's had said it had received a warning letter from the US Food and Drug Administration (USFDA) for three of its sites --...
Dr Reddys unveils generic Ciprodex in US to treat bacterial infection Farhat Nasim11 Aug 2020 10:01 AMNew Delhi: Dr Reddys Laboratories Ltd on Tuesday announced the launch of a generic version of Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%)...
Dr Reddys Labs PAT down by 13 percent to Rs 579.3 crore, gears up to launch 2 COVID drugs next month Ruchika Sharma31 July 2020 6:34 AMThe company has geared up to launch two anti-viral drugs Remdesivir and Favipiravir - for the treatment of COVID-19 next month.
Dr Reddy's Labs gets USFDA nod for lice treatment lotion XEGLYZE in US Ruchika Sharma28 July 2020 7:12 AMXEGLYZE is indicated for the topical treatment of head lice infestation in patients 6 months of age and older.
